The global low-grade glioma therapeutics market is expected to grow from US$ 1038 Million in 2023 to US$ 1515.47 Million by 2033, at a CAGR of 4.57% during the forecast period. The growth of the market is attributed to the increasing prevalence of low-grade glioma and the rising demand for effective and innovative treatments. Low-grade …
Category Archives: Healthcare Trends
Gastrointestinal Stromal Tumor (GIST) Therapeutics Market is expected to record a steady 6% CAGR over the period 2023 to 2033, as per the FMI report
During the forecast period 2023 to 2033, the Gastrointestinal stromal tumor (GIST) therapeutics market is expected to grow at a value of 6% CAGR, according to Future Market Insights. By the year 2033, the global market for Gastrointestinal stromal tumor (GIST) therapeutics is expected to rise up to a market valuation of US$ 1593 Million. …
Epidemic Keratoconjunctivitis Treatment Market is experiencing a steady growth with a CAGR of 5% during the period from 2023 to 2033
The global epidemic keratoconjunctivitis treatment market is anticipated to reach a market size of US$ 500 million in 2023 and US$ 814.45 million by exhibiting a CAGR of 5% from 2023 to 2033. From 2018 to 2022, the market for treating epidemic keratoconjunctivitis experienced a 4% CAGR. The successful management of epidemic keratoconjunctivitis is the …
Kyphoscoliosis Treatment Market Projects a 5% CAGR Growth from 2023 to 2033-FMI Projection
In the upcoming years, there is anticipated to be a significant increase in the global kyphoscoliosis treatments market due to factors like rising healthcare costs, increasing awareness of spinal disorders, increasing prevalence of kyphoscoliosis, and advancements in treatment options. According to a new market research report published by Future Market insights, the global kyphoscoliosis treatment …
Developmental and Epileptic Encephalopathies (DEE) Treatment Market Aims for US$ 11.4 Billion Valuation by 2033 -FMI Projection
The global Developmental and Epileptic Encephalopathies (DEE) Treatment Market is expected to generate a market value of US$ 7 billion in 2023 and a market value of US$ 11.4 billion by 2033, with a CAGR of 5% from 2023 to 2033. The market for Developmental and Epileptic Encephalopathies (DEE) Treatment grew at a 3.5% CAGR from 2018 …
Chronic Hepatitis B Virus Testing Market Achieves US$ 1790 Million Valuation in 2033| Future Market Insights,Inc.
During the forecast period 2023 to 2033, the Chronic Hepatitis B Virus Testing Market Sales is expected to grow at a value of 6.9% CAGR, according to Future Market Insights. By the year 2033, the global market for Chronic Hepatitis B Virus Testing is expected to rise up to a market valuation of US$ 1790 Million. Growth …
Cardiogenic Shock Treatment Market Sets Sights on a US$ 1.77 Billion Valuation by 2033 | Future Market Insights,Inc.
The global Cardiogenic Shock Treatment Market is expected to generate a market value of US$ 0.9 billion in 2023 and a market value of US$ 1.77 billion by 2033, with a CAGR of 7% from 2023 to 2033. Cardiogenic Shock Treatment market grew at a CAGR of 3.5% from 2018 to 2022. Cardiogenic shock is a life-threatening …
Cancer Vaccines Market Envisions a US$24.22 Billion Valuation by 2033 | Future Market Insights,Inc.
The global Cancer Vaccines Market is expected to generate a market value of US$ 9 billion in 2023 and a market value of US$ 24.22 billion by 2033, with a CAGR of 12% from 2023 to 2033. Cancer Vaccines market grew at a CAGR of 9% between 2018 and 2022. The cancer vaccine market is driven by …
Wilson’s Disease Diagnostics Market Poised for 3.9% CAGR Growth from 2023 to 2033| Future Market Insights,Inc.
Future Market Insights projects that the wilson’s disease diagnostics market will expand at a 3.9% compound annual growth rate (CAGR) from 2023 to 2033. Wilson’s disease diagnostics are predicted to reach a market size of US$ 896 million worldwide by 2033. The global market for Wilson’s disease diagnostics is expected to experience significant growth in …
Severe Asthma Treatment Market Anticipates a US$ 36.18 Billion Valuation in 2033-FMI Projection
According to Future Market Insights, the global Severe Asthma Treatment Market sales will expand at a 5.1% CAGR from 2023 to 2033, reaching US$ 36.18 billion by 2033. Severe Asthma Treatment has undergone a huge shift with the emergence of biologics and customised treatments, offering hope to millions of individuals worldwide who suffer from the disease. Biologics, …